Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

CGRP Administration Into the Cerebellum Evokes Light Aversion, Tactile Hypersensitivity, and Nociceptive Squint in Mice.

Authors:
Mengya Wang Thomas L Duong Brandon J Rea Jayme S Waite Michael W Huebner Harold C Flinn Andrew F Russo Levi P Sowers

Front Pain Res (Lausanne) 2022 25;3:861598. Epub 2022 Apr 25.

Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA, United States.

The neuropeptide calcitonin gene-related peptide (CGRP) is a major player in migraine pathophysiology. Previous preclinical studies demonstrated that intracerebroventricular administration of CGRP caused migraine-like behaviors in mice, but the sites of action in the brain remain unidentified. The cerebellum has the most CGRP binding sites in the central nervous system and is increasingly recognized as both a sensory and motor integration center. The objective of this study was to test whether the cerebellum, particularly the medial cerebellar nuclei (MN), might be a site of CGRP action. In this study, CGRP was directly injected into the right MN of C57BL/6J mice via a cannula. A battery of tests was done to assess preclinical behaviors that are surrogates of migraine-like symptoms. CGRP caused light aversion measured as decreased time in the light zone even with dim light. The mice also spent more time resting in the dark zone, but not the light, along with decreased rearing and transitions between zones. These behaviors were similar for both sexes. Moreover, significant responses to CGRP were seen in the open field assay, von Frey test, and automated squint assay, indicating anxiety, tactile hypersensitivity, and spontaneous pain, respectively. Interestingly, CGRP injection caused significant anxiety and spontaneous pain responses only in female mice, and a more robust tactile hypersensitivity in female mice. No detectable effect of CGRP on gait was observed in either sex. These results suggest that CGRP injection in the MN causes light aversion accompanied by increased anxiety, tactile hypersensitivity, and spontaneous pain. A caveat is that we cannot exclude contributions from other cerebellar regions in addition to the MN due to diffusion of the injected peptide. These results reveal the cerebellum as a new site of CGRP actions that may contribute to migraine-like hypersensitivity.

Download full-text PDF

Source
http://dx.doi.org/10.3389/fpain.2022.861598DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082264PMC
April 2022

Publication Analysis

Top Keywords

tactile hypersensitivity
16
cgrp
12
light aversion
12
spontaneous pain
12
female mice
8
cgrp injection
8
anxiety tactile
8
hypersensitivity spontaneous
8
cgrp caused
8
site cgrp
8
light
6
mice
6
hypersensitivity
5
zones behaviors
4
dark zone
4
light mice
4
mice spent
4
spent time
4
time resting
4
resting dark
4

Keyword Occurance

Similar Publications

Sensory hypo- and hypersensitivity in patients with brain tumors.

Authors:
Ryuta Ochi Shoko Saito Kentaro Hiromitsu Yayoi Shigemune Nobusada Shinoura Ryoji Yamada Akira Midorikawa

Brain Inj 2022 Aug 15:1-6. Epub 2022 Aug 15.

Department of Psychology, Chuo University, Tokyo, Japan.

Objectives: Hyper- and hyposensitivity in multiple modalities have been well-documented in subjects with autistic spectrum disorder (ASD) but not in subjects with acquired brain injury (ABI). The purpose of this study was to determine whether subjects with ABI experience altered sensory processing in multiple sensory modalities, and to examine the relationships between impaired sensory processing and the emotional state.

Methods And Procedures: Sixty-eight patients with brain or spinal cord tumors participated in the study. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

MAO-B inhibitor, KDS2010, alleviates spinal nerve ligation-induced neuropathic pain in rats through competitively blocking the BDNF/TrkB/NR2B signaling.

Authors:
Thuỳ Linh Phạm Chan Noh Chiranjivi Neupane Ramesh Sharma Hyun Jin Shin Ki Duk Park C Justin Lee Hyun-Woo Kim So Yeong Lee Jin Bong Park

J Pain 2022 Aug 5. Epub 2022 Aug 5.

Department of Medical Sciences, Graduate School; Department of Physiology, College of Medicine and Brain Research Institute, Chungnam National University, Daejeon, 35015, Korea; Laboratory of Veterinary Pharmacology, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 151-742, Korea. Electronic address:

MAO-B inhibitors have been implicated to reverse neuropathic pain behaviors. Our previous study has demonstrated that KDS2010 (KDS), a newly developed reversible MAO-B inhibitor, could attenuate Paclitaxel (PTX)-induced tactile hypersensitivity in mice through suppressing reactive oxidant species (ROS)-decreased inhibitory GABA synaptic transmission in the spinal cord. In this study, we evaluated the analgesic effect of KDS under a new approach, in which KDS acts on dorsal horn sensory neurons to reduce excitatory transmission. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Stimulation of CGRP-expressing neurons in the medial cerebellar nucleus induces light and touch sensitivity in mice.

Authors:
Mengya Wang William C Castonguay Thomas L Duong Michael W Huebner Harold C Flinn Agatha M Greenway Andrew F Russo Levi P Sowers

Neurobiol Pain 2022 Aug-Dec;12:100098. Epub 2022 Jun 23.

Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA 52242, USA.

Calcitonin gene-related peptide (CGRP) is considered a major player in migraine pathophysiology. However, the location and mechanisms of CGRP actions in migraine are not clearly elucidated. One important question yet to be answered is: Does central CGRP signaling play a role in migraine? One candidate site is the cerebellum, which serves as a sensory and motor integration center and is activated in migraine patients. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Analgesic and preventive effects of donepezil in animal models of chemotherapy-induced peripheral neuropathy: Involvement of spinal muscarinic acetylcholine M2 receptors.

Authors:
Marie Selvy Catherine Mattévi Cristelle Dalbos Youssef Aissouni Eric Chapuy Pierre-Yves Martin Aurore Collin Damien Richard Charles Dumontet Jérôme Busserolles Sakahlé Condé David Balayssac

Biomed Pharmacother 2022 May 6;149:112915. Epub 2022 Apr 6.

Université Clermont Auvergne, CHU Clermont-Ferrand, Délégation à la Recherche Clinique et à l'Innovation, INSERM U1107 NEURO-DOL, Clermont-Ferrand F-63000, France. Electronic address:

Background: Donepezil, a cholinesterase inhibitor approved in Alzheimer's disease, has demonstrated analgesic and preventive effects in animal models of oxaliplatin-induced neuropathy. To improve the clinical interest of donepezil for the management and prevention of chemotherapy-induced peripheral neuropathy (CIPN), a broader validation is required in different animal models of CIPN.

Methods: using rat models of CIPN (bortezomib, paclitaxel, and vincristine), the analgesic and preventive efficacies of donepezil were evaluated on tactile, cold and heat hypersensitivities. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Selective Targeting of Serotonin 5-HT1a and 5-HT3 Receptors Attenuates Acute and Long-Term Hypersensitivity Associated With Neonatal Procedural Pain.

Authors:
Anne R de Kort Elbert A Joosten Jacob Patijn Dick Tibboel Nynke J van den Hoogen

Front Pain Res (Lausanne) 2022 27;3:872587. Epub 2022 Apr 27.

Department of Anesthesiology and Pain Management, Maastricht University Medical Centre+, Maastricht, Netherlands.

Neonatal painful procedures causes acute pain and trigger long-term changes in nociceptive processing and anxiety behavior, highlighting the need for adequate analgesia during this critical time. Spinal serotonergic receptors 5-HT1a and 5-HT3 play an important role in modulating incoming nociceptive signals in neonates. The current study aims to attenuate acute and long-term hypersensitivity associated with neonatal procedural pain using ondansetron (a 5-HT3 antagonist) and buspirone (a 5-HT1a agonist) in a well-established rat model of repetitive needle pricking. Read More

View Article and Full-Text PDF
April 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap